Myofascial Trigger Point Pain

4

Review clinical trials related to Myofascial Trigger Point Pain. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Effect of Integrated Neuromuscular Inhibition Technique on Hand Grip Strength in Upper Trapezius Myofascial Trigger Points

This study aims to investigate the effects of the integrated neuromuscular inhibition technique on patients with upper trapezius myofascial trigger points by evaluating its impact on neck pain intensity, pressure pain threshold, hand grip strength, pinch grip strength, wrist joint range of motion, and upper extremity function.

Participants needed: 60
Trial details
Age: 18-55Biological sex: AllType: InterventionalSponsor: Cairo UniversityUpdated: May 15, 2026Locations: 1
Eligibility criteria

Subjects will be selected from out patient clinic of Delta University hospital,... [+7]

A history of any major neurological or musculoskeletal disorders, cardiovascular... [+4]

Status: Recruiting

The Effectiveness of Dry Needling Treatment in Patients Diagnosed With Dorsal Myofascial Pain Syndrome.

Back pain is commonly seen in the working-age population, with the peak occurrence around the age of 40. Its frequency does not increase with age and is not associated with age-related degenerative changes in the spine. Especially when the underlying cause is conditions such as myofascial pain syndrome (MPS), where regional muscle sensitivity in the rhomboid and trapezius areas is prominent, dry needling treatment has become increasingly popular and the subject of numerous studies in recent years. In the diagnosis of MPS, two valuable findings include the detection of a taut band upon palpation and the presence of trigger points in muscle fibers with mild finger pressure. The study we are planning involves a double-blind efficacy trial where real and sham dry needling procedures will be performed under ultrasound guidance, ensuring that both the patient and the evaluator are blinded. This study design has the potential to make a significant contribution to the literature in this field.

Participants needed: 50
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Kutahya Health Sciences UniversityUpdated: Sep 3, 2025Locations: 1
Eligibility criteria

Clinically diagnosed with Dorsal Myofascial Pain Syndrome associated with rhombo... [+2]

History of spinal surgery. [+6]

Status: Recruiting

The Therapeutic Effects of Dextrose Injection for Myofascial Pain Syndrome

Patients with an myofascial trigger point (MTrP) in their upper trapezius will be divided into three groups: Group A receiving MTrP injection with normal saline (control group), Group B with hypo-osmolar dextrose (5% dextrose), and Group C with hyper-osmolar dextrose (15% dextrose). Clinical outcomes and morphological changes will be measured before the injection, one hour after, one week after, two weeks after, and one month after the injection to delineate the therapeutic effects of dextrose injection for an MTrP.

Participants needed: 30
Trial details
Age: 20+Biological sex: AllType: InterventionalSponsor: National Cheng-Kung University HospitalUpdated: Jan 1, 2025Locations: 1
Eligibility criteria

1). Patients should be 20 years of age or older; [+5]

(1). acute or serious medical problems; [+8]

Status: Recruiting

Myofascial Release Technique in Women With Primary Dysmenorrhea

It has been found that women with dysmenorrhea have active trigger points, particularly in the rectus abdominis, oblique abdominal muscles, quadratus lumborum, and paraspinal muscles. The myofascial release technique is a widely used manual therapy method characterized by the application of low-load, long-duration mechanical forces to manipulate the myofascial complex. This technique aims to restore optimal length, alleviate pain, and improve function. This study aims to examine the effect of the myofascial release technique on central sensitization, myofascial trigger points, and menstrual symptoms in women with primary dysmenorrhea.

Participants needed: 36
Trial details
Age: 18-35Biological sex: FemaleType: InterventionalSponsor: Gazi UniversityUpdated: Nov 21, 2024Locations: 1
Eligibility criteria

Diagnosed with Primary Dysmenorrhea according to the Primary Dysmenorrhea Consen... [+2]

Diagnosed with Secondary Dysmenorrhea, [+7]